Last edition
News about
Yourway Adds 100,00 sq feet to their stock piling abilities
Expansion adds roughly 100,000 sq feet to existing storage capabilities at Allentown, PA, Headquarters.
Thermo Fisher's cyro-transmission electron microscope deployed at CCMB
Thermo Fisher Scientific's Cryo- Electron Microscopy Solutions to Help Drive Groundbreaking Structural Biology Research at the Centre for Cellular and Molecular Biology (CCMB)
Porvair Sciences displays examine units and microplates for Cancer Research
Porvair Sciences will display its measure packs and microplates for malignant growth and life science research at the American Association for Cancer Research (AACR) meeting in New Orleans, USA from the eighth - thirteenth April 2022.
Regeneron's Covid treatment review extended by FDA
The U.S. FDA is broadening the survey date for Regeneron Pharmaceuticals' COVID-19 immune response mixed drink back by 90 days. The choice was made after information showed it might assist with forestalling disease.
Effects of rilzabrutinib in individuals with insusceptible thrombocytopenia
Positive phase 1/2 study results of rilzabrutinib in people with immune thrombocytopenia published in The New England Journal of Medicine
Phosplatin with NIH start patient dosing in stage 2 preliminary of PT-112
Phosplatin Therapeutics Inc., a clinical stage pharmaceutical company, announced the first patient has been treated in a phase 2 clinical trial of the company's lead therapeutic candidate, PT-112, in patients with recurrent thymic epithelial tumours (TETs), specifically thymoma and thymic carcinoma.
Two ImmunoINSIGHTS contracts signed by Oncimmune
Oncimmune Holdings announces the signing of two new ImmunoINSIGHTS commercial contracts.
VectorBuilder spends USD 500M to build a new China campus
Chicago-based CDMO VectorBuilder just put up half a billion dollars to build a new manufacturing plant and research institute in Guangzhou, China.
Technology Development Center opened by ApiJect
ApiJect Systems, a provider of fill and finish services for injectable vaccines, has launched the ApiJect Technology Development Center in greater Orlando, FL.
Kyttaro and Lily come together to get license deal
UK-based startup Kyttaro and Eli Lilly have announced a new licensing deal.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy